Shepherd, Finkelman, Miller & Shah, LLP
65 Main StreetChester, CT 06412- 1311
Overview
Representation Of Anti-Kickback Whistleblowers
The widespread practice of pharmaceutical companies rewarding doctors for prescribing their medications was a major catalyst for the creation of the federal Anti-Kickback Statute. But with billions of dollars at stake, even the threat of major fines and criminal charges has not ended the lucrative under-the-table arrangements between doctors and drug makers. Furthermore, employees who report illegal kickbacks commonly...
Representation Of Anti-Kickback Whistleblowers
The widespread practice of pharmaceutical companies rewarding doctors for prescribing their medications was a major catalyst for the creation of the federal Anti-Kickback Statute. But with billions of dollars at stake, even the threat of major fines and criminal charges has not ended the lucrative under-the-table arrangements between doctors and drug makers. Furthermore, employees who report illegal kickbacks commonly...
Representation Of Anti-Kickback Whistleblowers
The widespread practice of pharmaceutical companies rewarding doctors for prescribing their medications was a major catalyst for the creation of the federal Anti-Kickback Statute. But with billions of dollars at stake, even the threat of major fines and criminal charges has not ended the lucrative under-the-table arrangements between doctors and drug makers. Furthermore, employees who report illegal kickbacks commonly experience retaliation.
The law firm of Shepherd, Finkelman, Miller & Shah, LLP (SFMS) represents whistleblowers in the pharmaceutical and health care industries who report anti-kickback violations. On behalf of plaintiffs, we have initiated qui tam lawsuits against major drug manufacturers for defrauding Medicare, Medicaid and other government programs through kickbacks to doctors.
In 2011, SMFS partner James E. Miller joined forces with two other firms in filing a False Claims Act whistleblower lawsuit against Novartis Pharmaceuticals Corp. The whistleblower, a former sales representative at Novartis, detailed a pattern of kickbacks to physicians who were most prolific in writing prescriptions for Novartis drugs. Based upon the solid foundation laid out by Mr. Miller and his co-counsel, the U.S. Department of Justice intervened in the case in 2013.
In a qui tam action, the first qualifying whistleblower to come forward is rewarded with a percentage of any money recovered by the government in its civil prosecution of the offending corporation. Contact us if you have knowledge of anti-kickback violations and want to explore your legal remedies and protections. SFMS maintains offices in California, Connecticut, Florida, New Jersey, New York, Pennsylvania and Wisconsin.
Call us at 860-526-1100
DISCLAIMER: If you send a lawyer or law firm email through this service, your email will not create an attorney-client relationship and will not necessarily be treated as privileged or confidential. You should not send sensitive or confidential information via this email service. The lawyer or law firm to whom you are writing may not choose to accept you as a client. Moreover, as the Internet is not necessarily a secure environment it is possible that your email sent via the Internet might be intercepted and read by third parties.